YC‐1 potentiates nitric oxide‐induced relaxation in guinea‐pig trachea
Open Access
- 1 October 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 128 (3) , 577-584
Abstract
The effects of YC‐1 (3‐(5′‐hydroxymethyl‐2′‐furyl)‐1‐benzylindazole) on tension, levels of cyclic GMP and cyclic AMP were investigated in guinea‐pig trachea. We especially studied the combined effect of YC‐1 with exogenous or endogenous nitric oxide on these parameters. YC‐1 at the concentration 3 or 10 μM, which caused only minor effect by itself, elicited concentration‐dependent potentiation of sodium nitroprusside (SNP)‐induced tracheal relaxation. This relaxation of YC‐1 with SNP was reversed by ODQ. Relaxant responses to electric field stimulation (EFS) in the presence of indomethacin, atropine, guanethidine, α‐chymotrypsin and histamine were also markedly increased by YC‐1 (10 μM). In the presence of L‐NAME or ODQ, the relaxant effects to EFS were attenuated and the following addition of YC‐1 did not further enhance relaxation. YC‐1 (10 μM) or SNP (0.3 μM) alone did not induce significant elevation of cyclic GMP levels in the presence of IBMX, whereas simultaneous application of both compounds markedly elevated the cyclic GMP accumulation. In contrast, the cyclic AMP levels were not altered even at the combination of YC‐1 and SNP. Additionally, YC‐1 also affected cyclic GMP metabolism, since it inhibited the activity of phosphodiesterase type V in human platelets. YC‐1 (30 μM) did not scavenge superoxide anion and had no effect on the removal of superoxide anion by superoxide dismutase in a xanthine/xanthine oxidase system. In conclusion, these results indicate that although YC‐1 elicits negligible relaxation of guinea‐pig trachea by itself, it can potentiate the relaxant responses of exogenous or endogenous NO. This synergistic response of YC‐1 is via the elevation of cyclic GMP contents. British Journal of Pharmacology (1999) 128, 577–584; doi:10.1038/sj.bjp.0702830Keywords
This publication has 32 references indexed in Scilit:
- Effects of the soluble guanylyl cyclase activator, YC‐1, on vascular tone, cyclic GMP levels and phosphodiesterase activityBritish Journal of Pharmacology, 1999
- Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside‐induced relaxation in guinea‐pig tracheaBritish Journal of Pharmacology, 1998
- Effect of YC‐1, an NO‐independent, superoxide‐sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilatorsBritish Journal of Pharmacology, 1997
- YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in miceEuropean Journal of Pharmacology, 1997
- Relaxation of guinea‐pig trachea by sodium nitroprusside: cyclic GMP and nitric oxide not involvedBritish Journal of Pharmacology, 1996
- Induction of guinea pig airway hyperresponsiveness by inactivation of guanylate cyclaseEuropean Journal of Pharmacology, 1996
- Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscleBritish Journal of Pharmacology, 1995
- l‐NG‐nitro arginine inhibits non‐adrenergic, non‐cholinergic relaxations of guinea‐pig isolated tracheal smooth muscleBritish Journal of Pharmacology, 1990
- THE RELATIONSHIP BETWEEN TISSUE LEVELS OF CYCLIC GMP AND TRACHEAL SMOOTH MUSCLE RELAXATION IN THE GUINEA‐PIGClinical and Experimental Pharmacology and Physiology, 1986
- Human blood platelet 3′:5′-cyclic nucleotide phosphodiesteraseBiochimica et Biophysica Acta (BBA) - Enzymology, 1976